LifeStance Health Group, Inc.

LFST Healthcare Medical Care Facilities

LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.

Revenue
+25.3%
EPS
+2,042.9%
Free cash flow
+31.6%
Total debt
−5.15%

Quarter to September 2026, against a year earlier

13.44 0.77 −5.42%
Market cap
$5.1B
P/E
70.7×
Fwd P/E
81.1×
Dividend yield
—
F-score
8/9
Altman Z
2.65
Beneish M
−2.96
Dividend safety
n/a

LifeStance Health Group, Inc. (LFST) Revenue growth

Alert me on Revenue growth

LifeStance Health Group, Inc.'s revenue growth over the twelve months to 30 September 2026 was 22.6%, up 8.8 percentage points from fiscal 2025 (13.9%). Over the past ten years it has ranged from −43.7% (fiscal 2019) to 77.5% (fiscal 2020); the current reading is higher than 29% of that period. That is above the Medical Care Facilities industry median of 6.38% and above the Healthcare sector median of 7.80%.

Revenue growth, annual

Embed this chart

Annual newest first

Period Revenue growth Change (points)
FY2025 13.9% (4.65)
FY2024 18.5% (4.32)
FY2023 22.8% (5.95)
FY2022 28.8% (48.19)
FY2021 77.0% (0.54)
FY2020 77.5% 121.16
FY2019 −43.7% —

Quarterly newest first

Period Revenue growth Change (points)
Sep 2026 25.3% (0.78)
Jun 2026 26.1% 4.91
Mar 2026 21.2% 3.74
Dec 2025 17.4% 1.09
23 more quarters

Against its own ten years

Low −43.7% High 77.5%
Ten-year median 22.8%
Current reading's percentile 29

Revenue growth against peers

What Revenue growth is

Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.

(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|

The full definition of Revenue growth →

More on LFST